In the transition from proliferating to hypertrophic cell zones in the growth plate, there is an increase in chondrocyte volume and a corresponding decrease in collagen content to accommodate the enlarging cells. It is postulated that collagenase accounts for this collagen loss. To test this hypothesis, tibial growth plates were obtained from normal rats, rachitic rats deficient in vitamin D and phosphate, and rats after 48 and 72 h of healing from rickets. Collagenase was quantitated by a pellet assay based on the release of solubilized collagen from the endogenous insoluble collagen in the tissue homogenates. A fourfold greater collagen release and a concomitant sixfold greater hypertrophic cell volume were measured in rachitic growth plates compared with normal age-matched controls. During healing of rickets, collagenase activity and hypertrophic cell volume returned almost to control levels. Rachitic growth plates were dissected into the juxtaepiphyseal 1/3 and the juxtametaphyseal ½3. The latter portion contained >95% of the hypertrophic cells and 86% of the collagenase. The collagendegrading activity was extracted from this region and was shown to be a true collagenase by its production of typical A fragments of tropocollagen produced by collagenase action. The enzyme was activated by aminophenylmercuric acetate and trypsin and was inhibited by EDTA, 1,10-phenanthroline, and a tissue inhibitor of metalloproteinases from human articular cartilage. Inhibitors of aspartic, cysteine, and serine proteases had no effect. Micropuncture fluids aspirated from rachitic cartilage contained latent collagenase activity, indicating an extracellular localization. Negative tests for hemoglobin in the rachitic cartilage samples indicated that there was no contamination by capillaries and that this was not a source of collagenase. It is concluded that extracellular collagenase accounts for the loss of cartilage matrix in the hypertrophic zone, and that this process may be distinct from that of capillary invasion.
Introduction
Calcification of growth cartilage results from a complex sequence of events that are poorly understood. Mineral deposition occurs extracellularly in a transforming matrix comprising collagens (1, 2) , glycoproteins (3), matrix vesicles (4) , and proteoglycans (5, 6) . Events that prepare the matrix for calci-fication are difficult to study in normal growth plates because of the very narrow zone in which mineralization occurs; this severely limits the size of samples for biochemical analysis. However, previous studies have shown that the sequence of mineralization events in healing rachitic rats closely duplicates the normal process, except that the hypertrophic zone is vastly expanded (7) . This model facilitates biochemical analysis. It has been shown that a macromolecular proteoglycan inhibitor potently inhibits mineral growth in this system (8) . An organic factor that rapidly generates mineral in the presence of metastable levels of mineral ions has also been detected in this system (9) . The extracellular location of aspirated micropuncture fluid has been firmly documented (10) . The current study is a continuation of this series of characterizations; it addresses the problem of hypertrophic cell enlargement adjacent to the site of fluid collection in the expanded rachitic growth plate. The hypothesis that collagen is removed by action of collagenase is tested by a direct tissue assay for collagenase activity. Evidence is presented that the enzyme is not produced by invading capillaries.
Methods
Animal and tissue preparation. Male Sprague-Dawley rats (35-45 g; Charles River Breeding Laboratories, Inc., Wilmington, MA) at age 21 d were randomly assigned to three different regimens. Group I, normal controls, were kept for 21-24 d on rat chow diet (Ralston Purina Co., St. Louis, MO) and water ad lib. Group II, animals rachitic due to low phosphate, vitamin D-deficient diet (-VDP)', were kept in the dark on U. S. Pharmacopeia Rachitogenic Diet No. 12 (calcium to phosphorus ratio, 5.85; Teklab Test Diets, Madison, WI) lacking vitamin D to induce -VDP rickets as described earlier (8, 1 1) . Group III, healing rachitic animals, received a single oral dose of vitamin D (Eli Lilly Co., Indianapolis, IN; ergocalciferol, 2,000 IU) after 21 d on the rachitogenic regimen. During healing, the rats were fed normal rat chow (Ralston Purina Co.) and water ad lib. for 2-3 d. All animals were sacrificed with sodium pentobarbital (10% in sterile water).
Histology and morphometry. The growth cartilage from the proximal tibias of both legs was excised from the surrounding tissues and trimmed under a dissecting microscope to exclude metaphyseal tissue and perichondrium. The tissue was then washed with sterile saline, blotted on tissue paper, and prepared for morphometry or enzyme assay. In some experiments the growth plates were also cut into two pieces: either the upper one-third (i.e., one-third of the distance from the resting cells to the mineralizing front) and lower two-thirds or the upper and lower one-half sections.
For histology, the tissues were fixed in 10% neutral formalin, decalcified in 0.5% formic acid for 1.5 h, embedded in paraffin, cut 1. Abbreviations used in this paper: APMA, aminophenylmercuric acetate; Cfl, cartilage extracellular fluid sampled by micropuncture aspiration; Hyp, hydroxyproline; TCA, the A fragment of tropocollagen produced by collagenase action; TIMP, tissue inhibitor of metalloproteinases; -VDP, animals rachitic due to low phosphate, vitamin D deficient diet.
Yellow. Morphometric analysis of cells and matrix in the proliferative and hypertrophic zones was performed according to standard stereological methods (12) under phase contrast microscopy (magnification of 320) using an ocular (E. Leitz, Inc., Rockleigh, NJ) containing a coherent lattice grid with a total of 324 points. The volume density measurements obtained by this method provide quantitative estimates of the fraction of total tissue volume occupied by the cells. The average number of fields scored per slide was approximately 12 and the total number of points scored per slide was approximately 3,800. Data were collected from six random sections from six animals in each experimental group. Statistical tests included analysis of variance and StudentNewman-Keuls multiple comparison test (13) .
Collagenase assay in tissue pellets. The assay is based on the principle that collagenase will digest endogenous collagen when homogenates are incubated at 370C. Insoluble collagen is separated from solubilized digestion products by centrifugation and the two collagen fractions are quantitated by their content of hydroxyproline (Hyp). Homogenates were prepared by the method of Morles et al. (14) and modified as follows. Epiphyseal growth plate cartilage (100 mg) was dissected, weighed, and placed in 25 vol ice-cold assay buffer (0.05 M Tris/HCI, 0.01 M CaC12, 0.15 M NaCl, pH 7.6, with 100 U penicillin and 100 Mg streptomycin/ml). The tissue was homogenized at 4VC using a hand-driven glass homogenizer (Duall #20; Kontes Co., Vineland, NJ). Cartilage pellets were prepared by centrifuging at 10,000 g for 20 min at 4VC and resuspending in the original volume of assay buffer.
Collagenase was activated by adding 5 Ml of trypsin (0.5 mg/ml; Worthington Diagnostics Div., Millipore Corp., Freehold, NJ) to 250
Ml of resuspended pellet. Samples were then incubated at 370C for 3 min, cooled in an ice bath, and treated with 5 Ml soybean trypsin inhibitor (2.5 mg/ml; Worthington Type Is) to block the trypsin. Alternatively, collagenase was activated with 1 mM aminophenylmercuric acetate (APMA). To determine optimal levels of activators and cofactors, various tests were performed. Trypsin activation was examined by adding trypsin to hypertrophic cell pellets, incubating for 3 min at 370C, and stopping the reaction with a fivefold weight excess of soybean trypsin inhibitor. APMA activation was tested by adding it at various levels to the incubation mixture. The calcium requirement was studied by varying the level of this ion with enzyme activated by APMA. To determine whether a second divalent cation was required, the enzyme was preincubated with I mM EDTA for I h at 370C in calcium-free assay buffer and then assayed in the presence of I mM APMA and 10 mM CaC12. Alternatively, the enzyme was inhibited with I mM 1,10-phenanthroline in the presence of excess calcium.
Incubations were performed in 1-ml Microflex tubes (Kontes Co.) with 25-Mul aliquots of the pellet homogenates prepared as above. The samples were paired and treated in four different ways. Group I contained the suspension alone, to test for enzyme already in an active form. Group II had added I mM 1,10-phenanthroline to block collagenase (= blank). Group Micropuncturefluid collagenase. To determine the enzyme activity present in cartilage micropuncture fluid, a microscale assay was employed, using soluble type I collagen purified from rat skin (see below).
On three occasions, a 100-nl sample of cartilage fluid (Cfl) was obtained by aspiration from six rachitic rats as previously described (11) .
Collagenolytic activity was measured by incubating the CH sample with 20 Mg unlabeled acid-soluble collagen for 48 h at 370C in 50 mM
Tris/HCI, 0.2 M NaCl, 10 mM CaCI2, 0.02% sodium azide, pH 7.5. Blanks contained 1,lO-phenanthroline. After centrifugation at 10,000 g for 20 min to remove undigested fibrils, the dried, hydrolyzed supernatants were suspended in 15 MI citric acid buffer, while the dried pellet was suspended in 50 Ml. Reagent volumes were adjusted to give a final volume, after color development, of 75 Mi for the supernatant and 250 Ml for the pellet. The absorbancy was read in a previouslydescribed microcuvette (16) . The activity was calculated as above for the pellet assay.
Extraction of collagenase. The extraction of enzyme followed the method of Sellers and Woessner (17) with slight modification. The lower two-thirds of the rachitic rat growth plate, containing the hypertrophic zone (100-120 mg from six rats), was homogenized with a hand-driven glass homogenizer (Duall #20; Kontes Co.) in 10 vol ice-cold 0.01 M CaCl2 containing 0.25% Triton X-100. The homogenates were centrifuged at 40C for 20 min at 10,000g. The pellet was resuspended in one-half the original volume of 0.05 M Tris/HCl, 0.1 M CaCI2, pH 7.5, and heated for 4 min at 60'C. Additional collagenase was extracted by repeating this heat step. The enzyme was activated by incubating with 0.5 mM APMA for I h at 370C, followed by dialysis against assay buffer. Assay of extracted collagenase on telopeptide-free collagen. Acid soluble type I collagen was obtained from rat skins by extraction in 0.5 M acetic acid. The solubilized collagen was precipitated with 1.7 M NaCI, dissolved in 50 mM Tris/HCI, 2 M urea, 0.3 M NaCl, pH 7.5, and then dialyzed against the same buffer without urea. The product was precipitated with ammonium sulfate (176 mg/ml) and then dissolved in 0.5 M acetic acid. Pepsinization and subsequent purification were carried out as described by Ryhanen et al. (18) . The purified collagen was then acetylated with [3Hlacetic anhydride (50 mCi/mmol; New England Nuclear, Boston, MA) at a ratio of I mCi/20 mg collagen as previously described (19, 20) . The specific activity of the final product was 6.5 X 103 cpm/Mg and the collagen was homogenous on sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis.
The method for measuring extracted collagenase activity was modified from that of Ryhanen et al. (18) . Telopeptide-free rat skin collagen (9 Mg, 6 X I0 cpm) was incubated with enzyme for 18 h at 30'C in a total volume of 110 Ml. The reaction was stopped with EDTA, carrier type I collagen without label was added, followed by trypsin and chymotrypsin to digest the products of collagenase action. Trichloroacetic acid was used to precipitate undigested collagen, which was then recovered on glass fiber filters. The filters were placed in 10 ml of scintillation fluid (Aquasol; New England Nuclear) and counted in a scintillation counter (Tri-Carb; Packard Instrument Co., Downers Grove, IL). Results were calculated as percent digestion after correction for buffer blanks. The assay was found to be linear with time over 24 h and up to 50% digestion of the collagen (not shown) SDS The pellet assay was shown to be linear over a 21-h incubation period and up to 42% digestion (Fig. 1) . In addition, since this method was originally developed for another tissue in which type I collagen was present (14) , the duration of centrifugation and the g-force were varied to determine the conditions necessary for pelleting the thinner type II collagen fibrils after the overnight incubation. It was found that the same amount of peptide-bound Hyp was present in the supernatant after centrifuging for either 30 min at 100,000 g or 20 min at 3,000 g; thus, the lower speed is adequate. Although these results establish the validity of this method for studying collagenolysis, the action of nonspecific metalloproteases cannot be completely excluded. Thus, we can't be certain that part of the collagen did not become denatured during the assay, or that we measured only type II collagen digestion and not that of type I or other minor collagens.
Using the pellet assay, whole growth plates from the four groups of animals were processed for collagenolytic activity ( Table I ). As can be seen, the Hyp content and tissue weight for the first three groups showed little change, but there was some decline in the last group. Collagenase activity, both total and active, increased almost fourfold in rickets, then returned to normal during healing. The cell volume showed only a twofold increase in rickets; however, this increase was due largely to an increase in the volume of hypertrophic cells (5.8-fold), whereas proliferative cell volume increased only slightly (1.5-fold). Thus, the change in collagenase level appears to correlate most closely with the change in hypertrophic cell volume. Statistical comparisons of the means of the various groups are summarized in Table II . We also examined 100-nl samples of micropuncture fluid. Three samples of rachitic fluid contained collagenase that, when activated by APMA, digested 1.71±0.27 gg collagen in 48 h at 370C using intact type I collagen as substrate. This constitutes further proof of the existence of a true collagenase in the cartilage.
The growth plates were sectioned into regions to determine if the enzyme activity would segregate with the hypertrophic cells as the above observations suggested. When the growth plates were cut in half, 62% of the total hypertrophic cell volume and only 8% of the proliferative cell volume was found in the lower half along with 58% of the collagenase (Table III) . Other growth plates were sectioned into upper one-third (63% proliferative cells) and lower two-thirds (95% hypertrophic cells). In this case, 86% of the collagenase activity was in the lower two-thirds; this corroborates the conclusion reached above that the enzyme is predominantly in the same region as the hypertrophic cells.
Some of the properties of the enzyme in the pellet assay are indicated in Table IV . The enzyme was activated with either 0.5 mM APMA or 10 ,sg/ml of trypsin and it required 10 mM CaCl2 for optimal activity. When the pellets were treated with low levels of EDTA after homogenization in calcium-free buffer, metalloprotease activity was blocked and the residual activity (4.5%) is attributed to action of nonspecific proteases or simple solubilization. If excess calcium (10 mM) is added, activity rises to 19% digestion, but not to the full value of 55%. This indicates that a second divalent cation such as zinc is probably required for full activity.
The collagenase activity in the lower two-thirds of rachitic growth plates was extracted by heating to 60°C for 4 min in 0.1 M CaCl2 after an initial homogenization in Triton X-100. This method has been used in our laboratories for extracting collagenase and neutral metalloproteases from the rat uterus (17) and proved effective with the growth plate as well. No further attempts were made to optimize the extraction since six animals were required for each new protocol. We plan to explore this point further in future work.
The properties of the extracted enzyme were investigated by use of the soluble collagen assay. It was found that the enzyme could be activated with APMA and trypsin and required calcium for activity, as in the pellet assay. These measurements avoided the 4.5% background seen with the pellet assay in the presence of chelators; inhibition by EDTA or phenanthroline was virtually complete. In addition, the enzyme digested soluble collagen in linear fashion up to 72 h incubation and up to 50% digestion of the substrate (data not shown). Growth plate collagenase produced the classic A fragment of tropocollagen (TCA) (Fig 2) ; the B fragments of tropocollagen produced by collagenase action were not readily visible and have probably been degraded by other proteases in the extract. The enzyme was also inhibited by tissue inhibitor of metalloproteinases (TIMP) (see ref. 23 ) isolated from human articular cartilage. Based on these observations, the enzyme activity associated with the release of Hyp from growth plate is a true collagenase.
Discussion
Our studies have shown for the first time that the hypertrophic region of rachitic growth cartilage produces a true collagenase. This activity has been studied using three different assay methods. The pellet assay is quantitative, but not completely specific; it measures only metal-dependent proteolysis, but this could include gelatinase as well as collagenase. If one accepts Phenylmethylsulfonyl fluoride (1 mM) 48±7.5 * Collagenase was measured by the pellet assay using tissue from the lower two-thirds of rachitic rat growth plate. * Treatments are described in Methods. The experiments in the calcium group and the protease inhibitor group had 1 mM APMA to activate the enzyme. In the calcium group, the EDTA was added to calcium-free pellets for I h at 370C and then incubated with AMPA±CaCl2-that gelatin is susceptible to nonspecific protease action, then the contribution from gelatin would probably be <5% digestion (Table IV, EDTA) . If the concentration of substrate were to vary widely from sample to sample (see Table I ), this might affect the enzyme kinetics. In our studies, the 72-h healing samples were the only ones to contain significantly lower amounts of collagen per milligram wet tissue; therefore, substrate concentration was not a critical factor, with the possible exception of this group. We assume that the enzyme was saturated during these assays since the reaction rate was linear from 0-21 h (Fig. 1) ; and Welgus et al. (24) have shown that only 10% of fibrillar collagen is available for binding to the enzyme, the deeper molecules become exposed only after digestion of the outer layer. The pellet assay includes minor collagens (1a, 2a, 3a, M, CFI; cf. ref. 25), which might contribute to the release of Hyp; also, it will not differentiate between type I and type II collagen. For these reasons, we used a second, more specific assay, and showed that extracts of rachitic growth plate contain a true collagenase based on the cleavage of collagen to typical TCA fragments of collagen at 30'C. Therefore, in the rachitic growth plate when 39% of the endogenous collagen is digested, there is no question that the bulk of this activity is due to the action of collagenase on type II collagen and not to gelatinase action or to digestion of minor collagens.
Of particular interest is the fact that the growth plate of the rachitic rats contains a large quantity of collagenase when compared with levels found in other tissues. A digestion of 39% (Table I) Table III ). The Hyp/ milligram wet tissue levels were decreased in the lower region compared with the upper region, providing additional evidence for collagenolysis in vivo. It is doubtful that collagenase arises from the invading vessels, since activity is reduced when vascular invasion is maximal.
That the enzyme is extracellular is indicated by the fact that it could be measured in the micropuncture fluids. The fluid contained only latent enzyme, indicating that the active form is probably bound to collagen fibers (31) .
In rickets, the increase in hypertrophic cell volume density is accompanied by an increase in collagenase. Collagenase is considered to be an extracellular enzyme, not stored in the cell (32) . A given volume of rachitic growth plate will then contain six times more cells and four times more collagenase than normal. The simplest explanation for this is that the cells continue to produce collagenase in rickets at levels just slightly lower than normal. As the cell population increases, collagenase increases almost in parallel. As rickets heal, the collagenase level drops below the normal level by 72 h, whereas the hypertrophic cell volume declines to a value still slightly above normal. This suggests that the hypertrophic cells during healing may diminish their production of collagenase. This is not unreasonable, if one considers that the space occupied by these cells has already been prepared and is now being consolidated by mineralization. These results on healing are surprising in light of the report by Amento et 
